Achieving the U.S. goal of reducing new HIV infections by 90% over 10 years will require accelerated efforts to diagnose, treat and prevent HIV, according to a new report from the Centers for Disease Control and Prevention. About 86% of the estimated 1.2 million Americans living with HIV in 2017 had received a laboratory-confirmed diagnosis and 63% of those diagnosed with HIV had the virus under control through effective treatment, the report notes. In 2018, about 18% of the estimated 1.2 million Americans who could benefit from preexposure prophylaxis (PrEP) received a prescription for the medication. The Department of Health and Human Services today launched a national program to make PrEP available at no cost to people without prescription drug insurance coverage. The number of new HIV infections remained relatively stable between 2013 and 2017 at about 38,000 per year. “The time is now to end HIV in America,” said CDC Director Robert Redfield, M.D. “We have the right tools, the right data and the right leadership to get this done.” In February, the administration proposed a national initiative to reduce new HIV infections by at least 90% by 2030 through testing, treatment and PrEP.

 

Related News Articles

Headline
The American Heart Association and American College of Cardiology Aug. 14 released new guidelines on high blood pressure prevention, suggesting earlier…
Headline
Josh Neff, CEO of CommonSpirit Mercy Hospital, discusses a new cutting-edge communication platform that sends patient EKGs directly from the ambulance to the…
Headline
A JAMA study published yesterday found that more adults age 45-49 have been diagnosed with colorectal cancer, a finding that coincides with recommendations by…
Headline
A study published June 25 by the Journal of the American Heart Association found that heart disease death rates fell 66% from 1970 to 2022. Deaths from heart…
Headline
The White House May 22 released its Make America Healthy Again report that focuses on childhood chronic disease. The report highlights findings from the MAHA…
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…